fenofibrate

After showing promise in early laboratory research, the cholesterol-lowering drug fenofibrate had no significant effect on COVID-19 outcomes in a multicenter international randomized clinical trial led by Penn Medicine scientists. The study…

The use of fenofibrate may be instrumental in reducing the risk of progression to vision-threatening diabetic retinopathy (VTDR). According to the findings of a recent study published in JAMA Ophthalmology, the use of fenofibrate was linked…

An oral drug used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, according to a study published on Friday. The team led by researchers from…